Autolus Therapeutics (AUTL) Depreciation and Depletion (2022 - 2025)

Autolus Therapeutics (AUTL) has 4 years of Depreciation and Depletion data on file, last reported at $2.1 million in Q4 2025.

• For the quarter ending Q4 2025, Depreciation and Depletion rose 5.0% year-over-year to $2.1 million; the trailing twelve-month figure through Dec 2025 stood at $8.3 million (up 9.21% YoY), and the FY2025 full-year result was $8.3 million, up 9.21% from the prior year.
• Depreciation and Depletion for Q4 2025 stood at $2.1 million, roughly flat from $2.1 million in the prior quarter.
• Across five years, Depreciation and Depletion topped out at $2.1 million in Q2 2025 and bottomed at $1.4 million in Q3 2023.
• The 4-year median for Depreciation and Depletion is $1.9 million (2023), against an average of $1.8 million.
• The widest annual swing landed in 2023, when Depreciation and Depletion declined 22.22%; it then surged 35.71% in 2024.
• A 4-year view of Depreciation and Depletion shows it stood at $1.6 million in 2022, then rose by 12.5% to $1.8 million in 2023, then gained by 11.11% to $2.0 million in 2024, then advanced by 5.0% to $2.1 million in 2025.
• The last three Depreciation and Depletion figures came in at $2.1 million (Q4 2025), $2.1 million (Q3 2025), and $2.1 million (Q2 2025), per Business Quant data.

Peer Comparison